Brief Report: Updated Data From IMscin001 Part 2, a Randomized Phase III Study of Subcutaneous Versus Intravenous Atezolizumab in Patients With Locally Advanced or Metastatic NSCLC

Autor: Burotto, Mauricio, Zvirbule, Zanete, Alvarez, Renzo, Chewaskulyong, Busayamas, Herraez-Baranda, Luis A., Shearer-Kang, Esther, Liu, Xiaoyan, Tosti, Nadia, Williams, Patrick, Castro Sanchez, Amparo Yovanna, Zanghi, James, Felip, Enriqueta
Zdroj: In Journal of Thoracic Oncology October 2024 19(10):1460-1466
Databáze: ScienceDirect